Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
13.13
-0.11 (-0.79%)
At close: Dec 31, 2025, 4:00 PM EST
13.12
-0.01 (-0.04%)
After-hours: Dec 31, 2025, 7:44 PM EST
Aardvark Therapeutics Employees
Aardvark Therapeutics had 22 employees as of December 31, 2024.
Employees
22
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,216,909
Market Cap
285.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AARD News
- 19 days ago - Aardvark's Hunger Suppressing Drug Candidate Could Potentially Address Massive $10 Billion Market: Analyst - Benzinga
- 21 days ago - Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome - GlobeNewsWire
- 5 weeks ago - Aardvark Therapeutics to Present at Upcoming Investor Conferences in December - GlobeNewsWire
- 6 weeks ago - Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates - GlobeNewsWire
- 7 weeks ago - Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 months ago - Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025 - GlobeNewsWire
- 2 months ago - Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 months ago - Aardvark Therapeutics to Present at Upcoming Investor Conferences in November - GlobeNewsWire